Quodlibet Naturopathics

Caffeine


No description available.



Caffeine may relate to these other naturopathic agents:


Caffeine is linked to these entities, through the following networks:

MAPK11 MAPK12 MAPK13 MAPK14 MTOR


Caffeine references used by Quodlibet:
  1. Caffeine inhibits UV-mediated NF-kappaB activation in A2058 melanoma cells: an ATM-PKCdelta-p38 MAPK-dependent mechanism.

    Mol Cell Biochem    2008 Jan;308(1-2):193-200




KEGG COMPOUND: C07481
Entry
C07481                      Compound                               

Name
Caffeine;
1,3,7-Trimethylxanthine
Formula
C8H10N4O2
Exact mass
194.0804
Mol weight
194.1906
Structure
Mol fileKCF fileDB searchJmolKegDraw
Remark
Same as: 
Reaction
Enzyme
1.13.12.-       1.14.13.178     1.14.13.179     1.14.14.1       
1.17.5.2        2.1.1.160
Brite
Phytochemical compounds [BR:br08003]
 Alkaloids
  Others
   Purine alkaloids
    C07481  Caffeine
Carcinogens [BR:br08008]
 Group 3: Not classifiable as to its carcinogenicity to humans
  Compounds
   C07481  Caffeine
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N06 PSYCHOANALEPTICS
   N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
    N06BC Xanthine derivatives
     N06BC01 Caffeine
      D00528  Caffeine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  21  Cardiovascular agents
   211  Cardiotonics
    2115  Caffeines
     D00528  Caffeine (USP); Anhydrous caffeine (JP17)
Classification of